NATURE

Nature

‌

 ‌

Abstract

Nucleic acid (NA) therapies represent major advances in the treatment of human diseases, and new approaches in NA design are required to improve gene editing technologies, cancer immunotherapies and epigenetic manipulation. The EU-funded NATURE-ETN project will create a network providing research training in the engineering of new biomaterials and therapies. The current research programme will include leading chemists and biologists in combination with technology and biotechnology partners. The network will use expertise in NA chemistry, DNA crystallography, materials chemistry, cell culture and epigenetic sequencing to develop a multidisciplinary environment to provide training to 15 early-stage researchers. The intersectoral training provided will encompass scientific and transferable skills, an understanding of the industry, and workshops in sequencing, genomics, and business management and future career planning.

Consortium

DCU (Coordinator), LMU Munich, University of Oxford, PSL University Paris, IOCB Prague, University of Reading, University of Warszawski, ATDBio LTD, Baseclick GMBH, NIBRT

For more information visit: NATURE